STOCK TITAN

Definitive Healthcare (DH) Stock Price, News & Analysis

DH NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
58 252 sessions, November 10, 2025 to November 10, 2026
Largest daily move
+18.4% close of August 31, 2026
1-year change
-58.2% closing prices, November 10, 2025 to November 10, 2026
1-month change
+21.4% closing prices, October 9, 2026 to November 10, 2026

Company Description

Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on the business side of the U.S. healthcare market. The company describes itself as an industry leader in healthcare commercial intelligence, providing information and insights that help organizations make smarter, faster and more strategic decisions across the healthcare ecosystem.

According to the company, the healthcare market is complex, and its data is intended to make that market clearer for customers. Definitive Healthcare states that it transforms data, analytics and expertise into healthcare commercial intelligence so clients can uncover the right markets, opportunities and people and shape tomorrow’s healthcare industry.

Business model and platform

Definitive Healthcare operates a SaaS-based healthcare commercial intelligence platform. As described in its public materials, the platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the United States. The company notes that its products and solutions create new paths to commercial success in the healthcare market, helping companies identify where to go next.

The platform uses deep analytics and data science to help customers develop data-driven strategic decisions. Examples cited by the company include finding new markets to enter, building go-to-market strategies, accessing tactical information to target appropriate decision makers, and improving win rates with detailed contextual information.

Definitive Healthcare reports that it derives substantially all of its revenue from subscription fees for access to its platform and stand-ready support. This subscription model aligns with its description of SaaS products and solutions that customers use on an ongoing basis.

End markets and use cases

Across its disclosures and press releases, Definitive Healthcare highlights that it serves a range of healthcare-related end markets. It references customer wins with organizations such as medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms, and healthcare advertising agencies. These examples illustrate how different types of organizations use its data, insights and integrations to support their critical business use cases.

The company emphasizes that its data and analytics help clients:

  • Uncover the right markets and opportunities in the healthcare sector
  • Identify and engage the right people and decision makers
  • Support go-to-market execution and sales targeting
  • Inform diligence and investment strategies in healthcare
  • Support service line expansion, physician recruitment and telemedicine growth for providers

Industry positioning and sector classification

Definitive Healthcare describes itself as a healthcare commercial intelligence and healthcare market data and analytics company. Based on the provided classification, it operates within the Professional, Scientific, and Technical Services sector and the industry category of Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology).

The company’s focus is on the information and analytics needs of the healthcare market rather than on direct patient care or the development of drugs or devices. Its role, as described in its own materials, is to cut through the noise of the healthcare market and deliver insights that organizations and companies can use to make more informed commercial decisions.

Geographic focus

Definitive Healthcare’s platform is described as providing information on the healthcare ecosystem in the United States. The company also notes that it derives a majority of its revenue from the United States, underscoring that its commercial intelligence and data assets are primarily oriented around the U.S. healthcare market.

Stock information and corporate structure

Definitive Healthcare Corp. is incorporated in Delaware and its common stock trades on the NASDAQ under the ticker symbol DH. SEC filings list its corporate name as Definitive Healthcare Corp. and confirm its status as a Delaware corporation.

Management, governance and disclosures

Through its SEC filings, the company discloses changes in its board and executive leadership, such as the resignation of directors, changes in committee roles, and adjustments to executive positions. It also reports inducement equity awards granted to senior leaders under its inducement plan, consistent with Nasdaq Listing Rule 5635(c)(4). These disclosures provide insight into how Definitive Healthcare manages executive compensation and leadership transitions.

The company regularly issues earnings press releases and files related Form 8-K reports to furnish financial results for its quarters and to provide financial guidance. These communications include discussions of non-GAAP financial measures such as Adjusted EBITDA, Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Unlevered Free Cash Flow, along with explanations of why management uses these metrics to evaluate performance.

Financial communication and non-GAAP metrics

In its earnings releases, Definitive Healthcare explains that it uses non-GAAP financial measures to focus on the performance of its core operations and to facilitate comparisons to historical periods and to other companies. The company provides definitions for metrics such as:

  • Adjusted EBITDA and Adjusted EBITDA Margin
  • Adjusted Gross Profit and Adjusted Gross Margin
  • Adjusted Operating Income
  • Adjusted Net Income and Adjusted Net Income Per Diluted Share
  • Unlevered Free Cash Flow

It also notes that these measures are supplemental, are not prepared in accordance with U.S. GAAP, and should not be considered substitutes for GAAP measures like net income, loss from operations, or cash provided by operating activities.

Investor communications and events

Definitive Healthcare frequently participates in investor conferences and hosts quarterly earnings calls and webcasts. The company announces the timing of these events in press releases and makes live audio webcasts available. It also states that it intends to use its website as a distribution channel for material company information, and that financial and other important information regarding the company is routinely posted and accessible there.

Status and continuity

Recent press releases and Form 8-K filings show that Definitive Healthcare continues to operate as a publicly traded company on NASDAQ under the symbol DH, reporting quarterly financial results, issuing financial guidance and making leadership and compensation disclosures. There is no indication in the provided materials of delisting, deregistration, bankruptcy, or completed merger transactions.

Stock Performance

$1.19
+6.25%
+0.07
Last updated: November 10, 2026 at 16:00
-58.2%
Performance 1 year
$127.5M

Definitive Healthcare (DH) closed at $1.19 on November 10, 2026. Over the past 12 months, the price has lost 58.2%.

See what a $1,000 investment in DH would be worth today

Average down calculator for DH

DH Metrics & Rankings

Price returns through November 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Definitive Healthcare has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, AI, conferences. View all DH news →

Financial Highlights

Definitive Healthcare generated $241.5M in revenue in FY2025, retaining a 75.9% gross margin, operating income reached -$224.3M (-92.9% operating margin), and net income was -$138.9M, reflecting a -57.5% net profit margin. Diluted earnings per share stood at -$1.30. The company generated $53.8M in operating cash flow. The current ratio was 1.64, measuring current assets divided by current liabilities.

$241.5M
Revenue (FY2025)
-$138.9M
Net Income (FY2025)
$53.8M
Operating Cash Flow

Upcoming Events

JUN
01
June 1, 2027 - June 1, 2030 Corporate

RSU vesting schedule

1,063,830 RSUs to Srinivas Attipalli: 25% vests 2027-06-01; remaining 75% vests at 6.25% quarterly through 2030-06-01.

Definitive Healthcare has 1 upcoming scheduled event. The next event, "RSU vesting schedule", is scheduled for June 1, 2027 (in 203 days). Investors can track these dates to stay informed about potential catalysts that may affect the DH stock price.

Short Interest History

Last 12 Months

Short interest in Definitive Healthcare (DH) currently stands at 1.9 million shares, up 15.0% from the previous reporting period, representing 5.4% of the float. Since November 2025, short interest has decreased by 44.7%.

Days to Cover History

Last 12 Months

Days to cover for Definitive Healthcare (DH) currently stands at 8.6 days, up 504.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 29.5%. Across the settlements charted above, it has ranged from 1.3 to 12.7 days.

DH Company Profile & Sector Positioning

Definitive Healthcare (DH) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing DH often look at related companies in the same sector, including Health Catalyst, Inc (HCAT), LifeMD, Inc. (LFMD), CareCloud, Inc. (CCLD), OptimizeRx Corporation (OPRX), and American Well Corporation (AMWL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DH's relative position within its industry.

Frequently Asked Questions

The current stock price of Definitive Healthcare (DH) is $1.19 as of November 10, 2026.

The market cap of Definitive Healthcare (DH) is approximately $127.5M. Learn more about what market capitalization means .

The FY2025 revenue of Definitive Healthcare (DH) is $241.5M, from its most recent completed fiscal year.

The FY2025 net income of Definitive Healthcare (DH) is -$138.9M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Definitive Healthcare (DH) is -$1.30 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Definitive Healthcare (DH) is $53.8M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Definitive Healthcare (DH) is -57.5% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Definitive Healthcare (DH) is -92.9% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Definitive Healthcare (DH) is 75.9% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Definitive Healthcare (DH), current assets divided by current liabilities, was 1.64 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Definitive Healthcare (DH) is $183.3M for FY2025, its most recent completed fiscal year.

The operating income of Definitive Healthcare (DH) is -$224.3M for FY2025, its most recent completed fiscal year. Learn about operating income.

Definitive Healthcare Corp. describes itself as a data and analytics company focused on the business side of healthcare. It provides healthcare commercial intelligence, using data, analytics and expertise to help organizations and companies understand the U.S. healthcare market and make more strategic decisions.

According to its public description, Definitive Healthcare derives substantially all of its revenue from the sale of subscription fees for access to its SaaS-based healthcare commercial intelligence platform and related stand-ready support.

The company uses the term healthcare commercial intelligence to describe the transformation of data, analytics and expertise into insights that help clients uncover the right markets, opportunities and people in healthcare. This intelligence is intended to support decisions such as market selection, go-to-market planning and targeting key decision makers.

In its earnings releases, Definitive Healthcare cites customer wins with organizations such as medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms, and healthcare advertising agencies. These examples indicate that it serves a range of healthcare-related commercial and provider organizations.

Definitive Healthcare states that its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the United States, and it notes that it derives a majority of its revenue from the United States.

Definitive Healthcare Corp.’s common stock trades on the NASDAQ under the ticker symbol DH, as referenced in multiple press releases and SEC filings.

The company states that the healthcare market is complex and that its data makes it clearer. It emphasizes that it cuts through the noise to deliver insights that help healthcare organizations and companies make smarter, faster and more strategic decisions, and that when its customers succeed, healthcare improves for a broader set of stakeholders.

In its earnings releases, Definitive Healthcare presents non-GAAP measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Operating Income, Adjusted Net Income, Adjusted Net Income Per Diluted Share and Unlevered Free Cash Flow. The company explains that these metrics are used by management and the board to assess operational performance and profitability.

Definitive Healthcare issues press releases announcing quarterly financial results, guidance and conference call details. It hosts earnings conference calls and webcasts and participates in investor conferences. The company also notes that it uses its website as a distribution channel for material company information, including financial updates.

Based on recent press releases and Form 8-K filings that report quarterly financial results, leadership changes and conference participation, Definitive Healthcare continues to operate as a publicly traded company on NASDAQ under the symbol DH. The provided materials do not indicate delisting, deregistration or bankruptcy.